Log In
Print this Print this

tivantinib (ARQ 197)

  Manage Alerts
Collapse Summary General Information
Company ArQule Inc.
DescriptionSmall molecule inhibitor of c-Met receptor tyrosine kinase
Molecular Target c-Met receptor tyrosine kinase (c-MET) (MET) (c-Met proto-oncogene)
Mechanism of Actionc-Met receptor tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today